Join Now

Category Archives: BioUtah News

Sumitomo Dainippon Pharma Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

CAMBRIDGE, Mass., April 10, 2021 — Sumitomo Dainippon Pharma Oncology, Inc., a clinicalstage company focused on research and development for novel cancer therapeutics, today presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I, taking place April 10-15, 2021. The […]

| Leave a comment

PhotoPharmics Innovations Address Global Health Inequalities

PhotoPharmics has announced its intent to leverage its FDA breakthrough device designation, potential streamlined Medicare coverage under CMS’ pending Medicare Coverage of Innovative Technology (MCIT) rule and global delivery channels to deliver its treatments for Parkinson’s and neurodegenerative diseases to individuals regardless of their location or income. Innovation not only brings improved treatments to address […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

SDP Oncology Presents New Data from Investigational Pipeline of Novel Cancer Therapeutics at AACR Virtual Annual Meeting I 2021

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently presented new findings on a range of investigational agents from the company’s pipeline at the American Association for Cancer Research (AACR) Virtual Annual Meeting I. The data presented at the meeting include preclinical and Phase 1 clinical data evaluating the potential anti-cancer activity of the PKM2 activator […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Christopher Phillips Named Chair of the BioUtah Regulatory, Compliance and Quality Committee

Fluidx’s regulatory and clinical affairs director will take the reins of the Regulatory, Compliance and Quality Committee, utilizing his expertise to help guide the regulatory and quality activities of BioUtah, the state’s premier life sciences trade association. Christopher Phillips, director of regulatory affairs and clinical affairs at Fluidx Medical Technology, has been appointed chair of […]

| Leave a comment

Innovative Med Tech Startup Xenter Announces Company Launch

Xenter has announced its formal launch in Salt Lake City. Founded in 2020 by seasoned life sciences entrepreneur Richard J. Linder, Xenter is innovating new wireless technologies and techniques for the treatment of heart and vascular disease. The company’s next-generation devices will integrate functions that formerly required multiple costly devices. “We are bringing the world’s […]

Also posted in Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

Utah’s Recursion Goes Public – Announces Pricing of IPO

Recursion Pharmaceuticals, Inc. today announced the pricing of its initial public offering of its Class A common stock at a price to the public of $18.00 per share. Recursion is offering 24,242,424 shares of its Class A common stock. The gross proceeds from the offering are expected to be $436.4 million. The shares are expected to […]

Also posted in Industry News, Press Releases, Utah's Life Sciences Companies | | Leave a comment

IONIQ Sciences Awarded Another Patent

IONIQ Sciences was awarded another patent for “an apparatus for providing information that is useful in the diagnosis of a malignant lung lesion.” IONIQ’s newest Notice of Allowance by the State Intellectual Property Office of the People’s Republic of China (SIPO) covers critical advancements and refinements to our proprietary algorithm, which calculates the likelihood a […]

| Leave a comment

IONIQ Sciences Announces Dr. Raphael E. Pollock Has Joined Its Medical Advisory Committee

IONIQ Sciences, Inc. recently announced that Raphael E. Pollock, MD, PhD, FACS has joined its Medical Advisory Committee. Dr. Pollock is an award-winning surgical oncologist, extensively published physician- scientist, Professor Emeritus in the Department of Surgical Oncology at MD Anderson Cancer Center and currently the Director of The Ohio State University Comprehensive Cancer Center (OSUCCC). […]

Also posted in Industry News, Life Sciences Industry News, Utah's Life Sciences Companies | | Leave a comment

The Element Awards 2021: LIfe Sciences Women in Business Honored

The St. George Area Chamber of Commerce hosted the First Annual Element Awards recognizing sixteen outstanding women of achievement in Washington County. The inaugural event was held March 26 at the Dixie Convention Center. These women, including women on the front lines of the life sciences, are building a legacy that future generations will emulate […]

| Leave a comment

BioHive Spotlight: Jeffery Nelson, Nelson Labs

Nelson Labs started in Utah and has grown under the leadership of Jeffery Nelson, Chairman of Nelson Labs. BIoHive turns the spotlight on Jeffery in this video as he talks about the company, its contributions to the life sciences industry and what it means to be a part. of BioHive. Nelson is “helping those innovators, […]

| Leave a comment

FDA Permits Marketing of BioFire COVID-19 Diagnostic Test Using Traditional Premarket Review Process

On March 17, the FDA granted marketing authorization of the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs (NPS) obtained from individuals suspected of COVID-19 and other respiratory tract infections. The diagnostic test, which had an Emergency […]

Also posted in COVID-19 Updates, HHS/FDA & Other Regulatory, Utah's Life Sciences Companies | | Leave a comment

Utah Legislature Appropriates $600,000 to support BioHive initiative

On the last day of the Utah legislative session, the legislature passed SB 2 “New Fiscal Year Supplemental Appropriations Act”.   Among the items funded was $600,000 to support the BioHive branding initiative.  In SB 3 entitled “Appropriations Adjustments” the language makes clear that the amount of the $600,000 to be released is dependent on 1:1 matching from […]

| Leave a comment